<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 S1123 IS: Office of National Drug Control Policy Reauthorization Act of 2017</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2017-05-15</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>115th CONGRESS</congress><session>1st Session</session>
		<legis-num>S. 1123</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20170515">May 15, 2017</action-date>
			<action-desc><sponsor name-id="S324">Mrs. Shaheen</sponsor> (for herself and <cosponsor name-id="S388">Ms. Hassan</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSJU00">Committee on the Judiciary</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To reauthorize the Office of National Drug Control Policy, and for other purposes.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short title; table of contents</header>
			<subsection id="id92EFB4B45D6C4A148A3F60A19CC85D21"><enum>(a)</enum><header>Short title</header>
 <text display-inline="yes-display-inline">This Act may be cited as the <quote><short-title>Office of National Drug Control Policy Reauthorization Act of 2017</short-title></quote>.</text>
 </subsection><subsection id="id35DE3383C081492780830B9F050B66B4"><enum>(b)</enum><header>Table of contents</header><text display-inline="yes-display-inline">The table of contents for this Act is as follows:</text><toc><toc-entry idref="S1" level="section">Sec. 1. Short title; table of contents.</toc-entry> <toc-entry idref="id79A550235AFB4D58B9EE3DBC58DD3C33" level="title">TITLE I—Organization of Office of National Drug Control Policy and roles and responsibilities</toc-entry> <toc-entry idref="id7bb0fb82f84b496082d1c871e2a0b8a6" level="section">Sec. 101. Amendments to definitions.</toc-entry> <toc-entry idref="id95cc0741f17b4cbd8847cb206d18fa2a" level="section">Sec. 102. Office of National Drug Control Policy.</toc-entry> <toc-entry idref="idb5726f747bbf498ba12f85d5b20e2e92" level="section">Sec. 103. Appointment and responsibilities of the Director.</toc-entry> <toc-entry idref="idfa721fe944cf4f2a8fe25564e3938097" level="section">Sec. 104. Coordination with other agencies.</toc-entry> <toc-entry idref="idE784FE2CAD884A2E941D52E3D4D3A646" level="title">TITLE II—The National Drug Control Strategy</toc-entry> <toc-entry idref="id719829b1032841c99aa528ca7854bf2a" level="section">Sec. 201. Annual preparation and submission of national drug control strategy.</toc-entry> <toc-entry idref="id1C7B0A8A6459435296C6A4D333A9FF1D" level="title">TITLE III—High intensity drug trafficking areas</toc-entry> <toc-entry idref="id5b612505e05547ee9fcdf2fd6ee2902e" level="section">Sec. 301. High intensity drug trafficking areas program.</toc-entry> <toc-entry idref="id3AE08A78E1184550B8586D45C6363BA0" level="title">TITLE IV—Drug interdiction coordinator and committee</toc-entry> <toc-entry idref="id78a5109dd104486a9467b6b16ffe81e5" level="section">Sec. 401. Drug interdiction coordinator.</toc-entry> <toc-entry idref="id7828B33D4B794BB4B8C1196CD1F3AC64" level="title">TITLE V—Authorization of appropriations and extension of termination date</toc-entry> <toc-entry idref="ide786d0f45d024592ad6d53a2bcdf85ae" level="section">Sec. 501. Authorization of appropriations.</toc-entry> <toc-entry idref="id738e54b7a015403488ee5e93de4d3dc9" level="section">Sec. 502. Extension of termination date.</toc-entry> <toc-entry idref="idDAA3220706CD4775ACB5017A28128CC3" level="title">TITLE VI—Amendments to the Office of National Drug Control Policy Reauthorization Act of 2006</toc-entry> <toc-entry idref="idea3e793faf994669bbd41b18432fef52" level="section">Sec. 601. Model Acts.</toc-entry> <toc-entry idref="idecc6fdb0962a4767837e41bf09c8186f" level="section">Sec. 602. Elimination of former reporting requirements.</toc-entry> </toc> </subsection></section><title id="id79A550235AFB4D58B9EE3DBC58DD3C33" style="OLC"><enum>I</enum><header>Organization of Office of National Drug Control Policy and roles and responsibilities</header> <section id="id7bb0fb82f84b496082d1c871e2a0b8a6"><enum>101.</enum><header>Amendments to definitions</header> <subsection id="id1ce7cb8318164dfa9f2baca52035409a"><enum>(a)</enum><header>Demand reduction</header><text>Section 702(1) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1701">21 U.S.C. 1701(1)</external-xref>) is amended—</text>
 <paragraph id="id7ee45e21f21e4c3caee218d573ad5aee"><enum>(1)</enum><text>by redesignating subparagraphs (A) through (H) as clauses (i) through (viii), respectively, and adjusting the margins accordingly;</text>
 </paragraph><paragraph id="id80113F76902A436796F0B44E1D7B98D7"><enum>(2)</enum><text>by redesignating subparagraphs (I) and (J) as clauses (xii) and (xiii), respectively, and adjusting the margins accordingly;</text>
 </paragraph><paragraph id="id7B0C5F0577324B7984FC591FD1E38411"><enum>(3)</enum><text>in the matter preceding clause (i), as so redesignated, by striking <quote><term>demand reduction</term> means</quote> and all that follows through <quote>including—</quote> and inserting the following:</text> <quoted-block display-inline="yes-display-inline" id="idA465F80630C44B5D893B11EBEDFAA898" style="OLC"> <text><term>demand reduction</term>—</text><subparagraph id="idF0E171F4494C4C58BC6DE916708991C7"><enum>(A)</enum><text>means any activity conducted by a National Drug Control Program agency, other than an enforcement activity, that is intended to reduce the use of drugs; and</text>
 </subparagraph><subparagraph id="id0D4BD530E9DC45A290C1183CA825925E"><enum>(B)</enum><text>includes prevention, treatment, and recovery efforts, such as—</text></subparagraph><after-quoted-block>;</after-quoted-block></quoted-block> </paragraph><paragraph id="idd46c7f126b79404f88ebcb2ace9638f3"><enum>(4)</enum><text>by inserting after clause (viii), as so redesignated, the following:</text>
						<quoted-block display-inline="no-display-inline" id="idc0e2aa4a787842dc88dee730ab19e772" style="OLC">
 <clause id="idbae11598839643a79c4813f3a065fdea"><enum>(ix)</enum><text>screening and brief interventions for substance use disorders;</text> </clause><clause id="idd5e6694cec884403ac175a0e82a951f6"><enum>(x)</enum><text>promoting availability of and access to health care services for the treatment of substance use disorders;</text>
 </clause><clause id="idbb105679520345a4bd9e4cae81dc56ae"><enum>(xi)</enum><text>support for long-term recovery from substance use disorders</text></clause><after-quoted-block>; and</after-quoted-block></quoted-block> </paragraph><paragraph id="idc5adfcf83d384e55a4f4a03ef6831ec5"><enum>(5)</enum><text>in clause (xiii), as so redesignated, by inserting <quote>recovery,</quote> after <quote>treatment,</quote>.</text>
 </paragraph></subsection><subsection id="id8a8b3a8830e544ef9a1f9b7f2fc182ac"><enum>(b)</enum><header>Appropriate congressional committees</header><text>Section 702(12) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1701">21 U.S.C. 1701(12)</external-xref>) is amended by inserting <quote>, the Committee on Health, Education, Labor, and Pensions</quote> before <quote>, the Committee on Appropriations</quote>.</text>
 </subsection><subsection id="idad178042ba124c1cb45b7b67bf388fb9"><enum>(c)</enum><header>Illicit drug use; illegal drug use</header><text>Section 702 of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1701">21 U.S.C. 1701</external-xref>) is amended by adding at the end the following:</text>
					<quoted-block display-inline="no-display-inline" id="id8D6DFE748917407F958AFF32DBC0CC4A" style="OLC">
 <paragraph id="id8F21B3FE01D047EF97F44A7299EF0BC6"><enum>(14)</enum><header>Illicit drug use; illegal drug use</header><text>The terms <term>illicit drug use</term>, <term>illegal drug use</term>, <term>illegal use of drugs</term>, <term>illicit use of drugs</term>, <term>illicit drug</term>, and <term>illegal drug</term> include the illegal use of prescription drugs.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block> </subsection></section><section id="id95cc0741f17b4cbd8847cb206d18fa2a"><enum>102.</enum><header>Office of National Drug Control Policy</header> <subsection id="id4CC89969EB1F4975B14E7F0CF726E33C"><enum>(a)</enum><header>Amendments</header><text display-inline="yes-display-inline">Section 703(b) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1702">21 U.S.C. 1702(b)</external-xref>) is amended—</text>
 <paragraph id="idb7cd4f3fa0564c54a9b5b9f5dc47dacb"><enum>(1)</enum><text>in the heading, by striking <quote><header-in-text level="subsection" style="USC">and Deputy Directors</header-in-text></quote>;</text> </paragraph><paragraph id="id493bd2f81b0942e7bcfdee938f2bbfc3"><enum>(2)</enum><text>by striking paragraph (2), and inserting the following:</text>
						<quoted-block display-inline="no-display-inline" id="id4982499ED52D4A60BAF62844D7F4C389" style="OLC">
 <paragraph id="id15FE7980E5D0478390A39D281142B171"><enum>(2)</enum><header>Responsibilities</header><text>The Director, and such members of the Office of National Drug Control Policy staff as designated by the Director, shall be responsible for demand reduction activities, supply reduction activities, and for State, local, and tribal affairs.</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block>
 </paragraph><paragraph id="id93A4AAFB7A9F4F3B8C64B2DB20C3DE9F"><enum>(3)</enum><text>by amending paragraph (3) to read as follows:</text> <quoted-block display-inline="no-display-inline" id="id4EF88F9ED55F417CB2E406F00C0F20DA" style="OLC"> <paragraph id="idEFFFABD31DAD49C18AE58D13D5D88849"><enum>(3)</enum><header>Other deputy directors</header><text>There shall be a Deputy Director for Demand Reduction, a Deputy Director for Supply Reduction, and a Deputy Director for State, Local, and Tribal Affairs.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
 </paragraph></subsection><subsection id="id4C16A1A3647146D383E4002AB446B692"><enum>(b)</enum><header>Effective date</header><text>The amendments made by subsection (a) shall take effect on October 1, 2017.</text> </subsection></section><section id="idb5726f747bbf498ba12f85d5b20e2e92"><enum>103.</enum><header>Appointment and responsibilities of the Director</header> <subsection id="id027dc983feb14eb494565d0c6d526f8b"><enum>(a)</enum><header>Appointment</header> <paragraph id="idE828D2FF26E64317BCE9B72E1DAF8BC1"><enum>(1)</enum><header>Amendments</header><text>Section 704 of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1703">21 U.S.C. 1703</external-xref>) is amended—</text>
 <subparagraph id="id225d62f4f1c540a2a52a30505c79579f"><enum>(A)</enum><text>in the heading, by striking <quote><header-in-text level="section" style="USC">and Deputy Directors</header-in-text></quote>; and</text> </subparagraph><subparagraph id="id6aefe73c97ec4887960e17e67f4913da"><enum>(B)</enum><text>in subsection (a)—</text>
 <clause id="id7A7427ACBC74426D86D19FDBFCCA7C48"><enum>(i)</enum><text>by amending paragraph (1) to read as follows:</text> <quoted-block display-inline="no-display-inline" id="id22BE4ABFCD744698AEA5EF69823A9DF0" style="OLC"> <paragraph id="idE3F49E0F08024F17B29080FD61D50414"><enum>(1)</enum><header>Director</header><text>The Director shall be appointed by the President, by and with the advice and consent of the Senate, and shall serve at the pleasure of the President.</text></paragraph><after-quoted-block>;</after-quoted-block></quoted-block>
 </clause><clause id="idE5E617CE13EE49A3B2A20E75FE21A94F"><enum>(ii)</enum><text>by striking paragraphs (2) and (3);</text> </clause><clause id="id5c6ddb6005ef481fa126d69b34448907"><enum>(iii)</enum><text>by redesignating paragraphs (4) and (5) as paragraphs (2) and (3), respectively; and</text>
 </clause><clause id="ida54436b868884dc5938883276118eb4e"><enum>(iv)</enum><text>in paragraph (2), as so redesignated, by striking <quote>or a Deputy Director</quote>.</text> </clause></subparagraph></paragraph><paragraph id="id014C420AB9FD46E99CFAD23997B5D3C3"><enum>(2)</enum><header>Effective date</header><text>The amendments made by paragraph (1) shall take effect on January 20, 2018.</text>
 </paragraph></subsection><subsection id="id155df1183d8f44ac96691466d0e59e75"><enum>(b)</enum><header>Responsibilities</header><text>Subsection 704(b) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1703">21 U.S.C. 1703(b)</external-xref>) is amended—</text>
 <paragraph id="id5e51a56aecf04532861f3ab4c3d63b8c"><enum>(1)</enum><text>in paragraph (13)(E), by striking <quote>treatment and prevention</quote> and inserting <quote>treatment, prevention, and recovery support</quote>;</text> </paragraph><paragraph id="id0595fc4d940543508a7c54d70da3af30"><enum>(2)</enum><text>in paragraph (15), by striking <quote>prevention and drug treatment</quote> and inserting <quote>prevention, drug treatment, and recovery</quote>;</text>
 </paragraph><paragraph id="id75c6ae7fcdcb41c2bdc620c0abf05030"><enum>(3)</enum><text>in paragraph (18), by adding <quote>and</quote> after the semicolon;</text> </paragraph><paragraph id="idb570880409e64eb7ab4e9956acd577f7"><enum>(4)</enum><text>in paragraph (19), by striking <quote>; and</quote> and inserting a period; and</text>
 </paragraph><paragraph id="idcd8563fc4743400ebbf6a163b0a1d07c"><enum>(5)</enum><text>by striking paragraph (20).</text> </paragraph></subsection><subsection id="id684c91c321444831ad53691c369908cb"><enum>(c)</enum><header>Fund control notices</header><text>Section 704(f) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1703">21 U.S.C. 1703(f)</external-xref>) is amended—</text>
 <paragraph id="id5cf2635d6b4e4498bac99642ed07fd05"><enum>(1)</enum><text>in the first paragraph (5), in subparagraph (A), by inserting <quote>or statute</quote> after <quote>appropriation</quote>;</text> </paragraph><paragraph id="id580DD72F4A8A401AA726BFC337083CC5"><enum>(2)</enum><text>by striking the second paragraph (4); and</text>
 </paragraph><paragraph id="id26CDEED3E68B4C95A5B4F470DF3D2400"><enum>(3)</enum><text>by striking the second paragraph (5).</text> </paragraph></subsection></section><section id="idfa721fe944cf4f2a8fe25564e3938097"><enum>104.</enum><header>Coordination with other agencies</header><text display-inline="no-display-inline">Section 705(d) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1704">21 U.S.C. 1704(d)</external-xref>) is amended—</text>
 <paragraph id="idbe4713ae0b7c4f909311321e3e4e2c89"><enum>(1)</enum><text>in the header by striking <quote><header-in-text level="subsection" style="USC">expended</header-in-text></quote> and inserting <quote><header-in-text level="subsection" style="USC">obligated</header-in-text></quote>; and</text> </paragraph><paragraph id="id31737AFE20FA496D8C1BD931A4C53C3D"><enum>(2)</enum><text>in paragraph (A), by striking <quote>(A) require</quote> and inserting <quote>(1) require</quote>.</text>
 </paragraph></section><section id="id58410A218D004E67B8424378278CD68B"><enum>105.</enum><header>Report on internet purchasing of synthetic drugs and precursor chemicals</header><text display-inline="no-display-inline">Not later than 180 days after the date of enactment of this Act, the Director of National Drug Control Policy, in consultation with the Attorney General and the Administrator of the Drug Enforcement Administration, shall submit to Congress a report on Internet purchasing of synthetic drugs and precursor chemicals that includes—</text>
 <paragraph id="idea81c244967b42c1b033001f53c8ea58"><enum>(1)</enum><text>how purchases of synthetic drugs and precursor chemicals are conducted on the open Internet and the dark web;</text>
 </paragraph><paragraph id="id1cccb9a9741749ea85aa469ab3a9b417"><enum>(2)</enum><text>the scale of the problem described in paragraph (1);</text> </paragraph><paragraph id="idf934b7a0f1364fc48554c7df9f503d2b"><enum>(3)</enum><text>the country of origin of the relevant Web sites, manufacturers, and distributors;</text>
 </paragraph><paragraph id="id8b4a28818cd54b2198a3788dc87ddad8"><enum>(4)</enum><text>measures that can be taken to eliminate the sale of synthetic drugs and precursor chemicals over the Internet; and</text>
 </paragraph><paragraph id="idd9265262ac80497da9d56eb06a0694d0"><enum>(5)</enum><text>any recommendations for legislation necessary to eliminate the sale of synthetic drugs and precursor chemicals over the Internet.</text>
				</paragraph></section></title><title id="idE784FE2CAD884A2E941D52E3D4D3A646" style="OLC"><enum>II</enum><header>The National Drug Control Strategy</header>
 <section id="id719829b1032841c99aa528ca7854bf2a"><enum>201.</enum><header>Annual preparation and submission of national drug control strategy</header><text display-inline="no-display-inline">Section 706(a) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1705">21 U.S.C. 1705(a)</external-xref>) is amended—</text>
 <paragraph id="id4c5835bd50a142dfb8402ed62eca6d4b"><enum>(1)</enum><text>in paragraph (1) by inserting before the period <quote>, and by promoting prevention, early intervention, treatment, and recovery support for individuals with substance use disorders</quote>;</text>
 </paragraph><paragraph id="idaa5813d66a4a4c87ac5a583b7b807a35"><enum>(2)</enum><text>in paragraph (2)(A)—</text> <subparagraph id="idACB9C5C484564822A8987500CEADC7A5"><enum>(A)</enum><text>in clause (i), by inserting <quote>, including the misuse of prescription drugs,</quote> before <quote>and the</quote>;</text>
 </subparagraph><subparagraph id="id18057dee331b4da9a4b58332fe5ef3fe"><enum>(B)</enum><text>by striking clause (ix); and</text> </subparagraph><subparagraph id="idA1F10A342EC24AFE86A4668FB803D749"><enum>(C)</enum><text>by redesignating clauses (x) through (xiv) and clauses (ix) through (xiii), respectively; and</text>
 </subparagraph></paragraph><paragraph id="idC351FF6BC9194098A9DB891826C87FE5"><enum>(3)</enum><text>in paragraph (3)—</text> <subparagraph id="idA28165C6107145AA811474D8B08ABB0C"><enum>(A)</enum><text>in subparagraph (B), by inserting <quote>and</quote> at the end;</text>
 </subparagraph><subparagraph id="id88D752CB09DE4688A0CA7A74A5379922"><enum>(B)</enum><text>in subparagraph (C), by striking <quote>; and</quote> and inserting a period; and</text> </subparagraph><subparagraph id="idb15b69625f954af98edd0dc4f0dce97d"><enum>(C)</enum><text>by striking subparagraph (D).</text>
					</subparagraph></paragraph></section></title><title id="id1C7B0A8A6459435296C6A4D333A9FF1D" style="OLC"><enum>III</enum><header>High intensity drug trafficking areas</header>
 <section id="id5b612505e05547ee9fcdf2fd6ee2902e"><enum>301.</enum><header>High intensity drug trafficking areas program</header><text display-inline="no-display-inline">Section 707 of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1706">21 U.S.C. 1706</external-xref>) is amended—</text>
 <paragraph id="id04B85D3C74C346E9A0C0BF2A16789B46"><enum>(1)</enum><text display-inline="yes-display-inline">by striking subsections (k), (l), and (m) and inserting the following:</text> <quoted-block display-inline="no-display-inline" id="idd046fbbb29564cf6854a956bf3571a4c" style="OLC"> <subsection id="id81b4de634abe4672874e4b417f48eb2a"><enum>(k)</enum><header>Evaluation of HIDTA as part of the national drug control strategy</header> <paragraph id="id446b0dd86fe041cf9aa2e0292ee6ea51"><enum>(1)</enum><header>Report</header><text>The Director shall, as part of the National Drug Control Strategy and after consulting with the Executive Boards of each designated high intensity drug trafficking area, submit a report to Congress that describes, for each designated high intensity drug trafficking area—</text>
 <subparagraph id="idad52074a6c274897a36f4ab3a5e0d4eb"><enum>(A)</enum><text>the specific purposes for the high intensity drug trafficking area;</text> </subparagraph><subparagraph id="id54c9fe1c64a540019680cca950c6dee4"><enum>(B)</enum><text>the specific long-term and short-term goals and objectives for the high intensity drug trafficking area;</text>
 </subparagraph><subparagraph id="id2b6ab3b3824a42d4a80caf55acce0b08"><enum>(C)</enum><text>the measurements that will be used to evaluate the performance of the high intensity drug trafficking area in achieving the long-term and short-term goals;</text>
 </subparagraph><subparagraph id="idf5c67ea0b33f4966b302589a8e575760"><enum>(D)</enum><text>the reporting requirements needed, if appropriate, to evaluate the performance of the high intensity drug trafficking area in achieving the long- and short-term goals; and</text>
 </subparagraph><subparagraph id="id5593e470c9944e89918f76e48fd43782"><enum>(E)</enum><text>an evaluation of the performance of the high intensity drug trafficking area in accomplishing the specific long-term and short-term goals and objectives identified under subparagraph (B).</text>
 </subparagraph></paragraph><paragraph id="id42fb851a3c8e4efca52af3bd9d8fe458"><enum>(2)</enum><header>Assessment of drug enforcement task forces in high intensity drug trafficking areas</header><text>The Director, as part of the report required under paragraph (1), shall—</text> <subparagraph id="id24b54656206a48cfbc8be622b6628869"><enum>(A)</enum><text>assess the number and operation of all federally funded drug enforcement task forces within each high intensity drug trafficking area; and</text>
 </subparagraph><subparagraph id="id0423dd9fadee45df93c886394b76c3bd"><enum>(B)</enum><text>describe—</text> <clause id="id4da4f39606d5400e94887c8e8b3dbe08"><enum>(i)</enum><text>each Federal, State, local, and tribal drug enforcement task force operating in the high intensity drug trafficking area;</text>
 </clause><clause id="id7d44824e3b14421885945f286e5a69c5"><enum>(ii)</enum><text>how such task forces coordinate with each other, with any high intensity drug trafficking area task force, and with investigations receiving funds from the Organized Crime and Drug Enforcement Task Force;</text>
 </clause><clause id="idacebeb68b5344cdd8256d14a0908444f"><enum>(iii)</enum><text>what steps, if any, each such task force takes to share information regarding drug trafficking and drug production with other federally funded drug enforcement task forces in the high intensity drug trafficking area;</text>
 </clause><clause id="id5bfbd05f2ef74907a80d527d9d72b1f5"><enum>(iv)</enum><text>the role of the high intensity drug trafficking area in coordinating the sharing of such information among task forces;</text>
 </clause><clause id="id5a2e9ad7aef1423eb30a40b6162092c9"><enum>(v)</enum><text>the nature and extent of cooperation by each Federal, State, local, and tribal participant in ensuring that such information is shared among law enforcement agencies and with the high intensity drug trafficking area;</text>
 </clause><clause id="idbd449181ba98439caab8e61f9a9177d0"><enum>(vi)</enum><text>the nature and extent to which information sharing and enforcement activities are coordinated with joint terrorism task forces in the high intensity drug trafficking area; and</text>
 </clause><clause id="idb70e4629276c4e7aadbe01bab2ea81d4"><enum>(vii)</enum><text>any recommendations for measures needed, if appropriate, to ensure that task force resources are utilized efficiently and effectively to reduce the availability of illegal drugs in the high intensity drug trafficking areas.</text>
 </clause></subparagraph></paragraph><paragraph id="id53b76c4110fa4e68a785c94ec6f0c9ad"><enum>(3)</enum><header>Assessment of law enforcement intelligence sharing in high intensity drug trafficking areas program</header><text>The Director, as part of the report required under paragraph (1), shall—</text> <subparagraph id="idbed71e0c183f48d3bbf23015f660ac32"><enum>(A)</enum><text>evaluate existing and planned law enforcement intelligence systems supported by each high intensity drug trafficking area, or utilized by task forces receiving any funding under the Program, including the extent to which such systems ensure access and availability of law enforcement intelligence to Federal, State, local, and tribal law enforcement agencies within the high intensity drug trafficking area and outside of it;</text>
 </subparagraph><subparagraph id="id976f6e4086ea4ac3b3e6c2bfc7b92773"><enum>(B)</enum><text>describe the extent to which Federal, State, local, and tribal law enforcement agencies participating in each high intensity drug trafficking area are sharing law enforcement intelligence information to assess current drug trafficking threats and design appropriate enforcement strategies; and</text>
 </subparagraph><subparagraph id="iddc8917adf6d04c42907a26656cb282ff"><enum>(C)</enum><text>describe the measures needed, if appropriate, to improve effective sharing of information and law enforcement intelligence regarding drug trafficking and drug production among Federal, State, local, and tribal law enforcement participating in a high intensity drug trafficking area, and between such agencies and similar agencies outside the high intensity drug trafficking area.</text></subparagraph></paragraph></subsection><after-quoted-block>;</after-quoted-block></quoted-block>
 </paragraph><paragraph id="ida72a33638f6b4d95861159f4435450cc"><enum>(2)</enum><text>by redesignating subsections (n), (o), (p), and (q) as subsections (l), (m), (n), and (o), respectively; and</text>
 </paragraph><paragraph id="ide0a933b47ff94dc1b4bf7fabf312d688"><enum>(3)</enum><text>by amending subsection (n), as so redesignated, to read as follows:</text> <quoted-block display-inline="no-display-inline" id="idDE3B4CE2CABD487D879AF0EA024037E4" style="OLC"> <subsection id="id44994ADFECAA482E80CF69C9824808C2"><enum>(n)</enum><header>Authorization of appropriations</header><text>There is authorized to be appropriated to the Office of National Drug Control Policy $290,000,000 for fiscal year 2018 and such sums as are necessary to carry out this section for each of fiscal years 2019 through 2023.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section></title><title id="id3AE08A78E1184550B8586D45C6363BA0" style="OLC"><enum>IV</enum><header>Drug interdiction coordinator and committee</header>
 <section id="id78a5109dd104486a9467b6b16ffe81e5"><enum>401.</enum><header>Drug interdiction coordinator</header><text display-inline="no-display-inline">Section 711 of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1710">21 U.S.C. 1710</external-xref>) is amended—</text>
 <paragraph id="id11503166612F4389B217D84DDB9BD279"><enum>(1)</enum><text display-inline="yes-display-inline">in subsection (a)—</text> <subparagraph id="id82558cd6ec9f4fed9ae7782a6be45af5"><enum>(A)</enum><text>in paragraph (2)—</text>
 <clause id="idE167385AC77745A2A8E92A2A4313A976"><enum>(i)</enum><text>in subparagraph (B)—</text> <subclause id="id8D2A295C997440BD9691062C79A72ED8"><enum>(I)</enum><text>by striking <quote>on or before March 1 of each year and</quote>;</text>
 </subclause><subclause id="id36DDD401D8A444AFAD03207192D7C302"><enum>(II)</enum><text>by striking <quote>Command and Control</quote> and inserting <quote>Coordination</quote>; and</text> </subclause><subclause id="id1BD00733E87C4E06A1743E576BD66B11"><enum>(III)</enum><text>by inserting <quote>and revising the plan as necessary on or before March 1 of each year</quote> before the semicolon at the end; and</text>
 </subclause></clause><clause id="id93EAFF213CFB48E49EB1A659375431DA"><enum>(ii)</enum><text>in subparagraph (D), by striking <quote>Command and Control</quote> and inserting <quote>Coordination</quote>;</text> </clause></subparagraph><subparagraph id="idd40701bf89a34d9e84376f503c09a003"><enum>(B)</enum><text>in paragraph (3), by striking <quote>to the Office of Supply Reduction for that purpose</quote> and inserting <quote>to the Office to assist the United States Interdiction Coordinator in carrying out the responsibilities described in paragraph (2)</quote>; and</text>
 </subparagraph><subparagraph id="id7ce0a4bfb3b647f5bb5044857ed0941b"><enum>(C)</enum><text>in paragraph (4)—</text> <clause id="idA490FD6DB7CE4FA086225611A7D9BA11"><enum>(i)</enum><text>by striking <quote>Command and Control</quote> each time that term appears and inserting <quote>Coordination</quote>;</text>
 </clause><clause id="id596f0a1437c34285a975b1c0be5e3490"><enum>(ii)</enum><text>in subparagraph (A)(iii), by striking <quote>required</quote> and inserting <quote>that will be used</quote>; and</text> </clause><clause id="idb6b5b1246d55423488ca82ea1c4f3407"><enum>(iii)</enum><text>in subparagraph (D), by striking <quote>include</quote> and all that follows through the period at the end and inserting <quote>a copy of the current National Interdiction Coordination Plan and the most recent Interdiction Performance Assessment.</quote>; and</text>
 </clause></subparagraph></paragraph><paragraph id="id5CE7DB516D24488BB32747651F549B9C"><enum>(2)</enum><text>in subsection (b)(1)(B)—</text> <subparagraph id="idA6560CD33BFE49C599C4CC6A3193FBB4"><enum>(A)</enum><text>by striking <quote>annual</quote> and inserting <quote>revised</quote>; and</text>
 </subparagraph><subparagraph id="idEEFB8103038A4F2F82FA1DA0A92495D2"><enum>(B)</enum><text>by striking <quote>Command and Control</quote> and inserting <quote>Coordination</quote>.</text> </subparagraph></paragraph></section></title><title id="id7828B33D4B794BB4B8C1196CD1F3AC64" style="OLC"><enum>V</enum><header>Authorization of appropriations and extension of termination date</header> <section id="ide786d0f45d024592ad6d53a2bcdf85ae"><enum>501.</enum><header>Authorization of appropriations</header><text display-inline="no-display-inline">Section 714 of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1711">21 U.S.C. 1711</external-xref>) is amended by striking <quote>2006 through 2010</quote> and inserting <quote>2018 through 2023</quote>.</text>
 </section><section id="id738e54b7a015403488ee5e93de4d3dc9"><enum>502.</enum><header>Extension of termination date</header><text display-inline="no-display-inline">Section 715(a) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1712">21 U.S.C. 1712(a)</external-xref>) is amended by striking <quote>2010</quote> and inserting <quote>2023</quote>.</text>
			</section></title><title id="idDAA3220706CD4775ACB5017A28128CC3" style="OLC"><enum>VI</enum><header>Amendments to the Office of National Drug Control Policy Reauthorization Act of 2006</header>
 <section id="idea3e793faf994669bbd41b18432fef52"><enum>601.</enum><header>Model Acts</header><text display-inline="no-display-inline">Section 1105 of the Office of National Drug Control Policy Reauthorization Act of 2006 (<external-xref legal-doc="usc" parsable-cite="usc/21/1701">21 U.S.C. 1701</external-xref> note) is amended by striking subsection (b) and inserting the following:</text>
				<quoted-block display-inline="no-display-inline" id="id561E8E417CF64705B7A4BE0CD937D983" style="OLC">
 <subsection id="id2B95B9DAF8AD4EE3A8AA1A80763543D8"><enum>(b)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There is authorized to be appropriated to carry out this subsection such sums as are necessary for each of fiscal years 2018 through 2023.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
 </section><section id="idecc6fdb0962a4767837e41bf09c8186f"><enum>602.</enum><header>Elimination of former reporting requirements</header><text display-inline="no-display-inline">The Office of National Drug Control Policy Reauthorization Act of 2006 (<external-xref legal-doc="public-law" parsable-cite="pl/109/469">Public Law 109–469</external-xref>; 120 Stat. 3502) is amended—</text>
 <paragraph id="idb7bc263f63cd4bb6946e180317173da5"><enum>(1)</enum><text>in section 802 (120 Stat. 3535)—</text> <subparagraph id="id34D17B018F8D44F6B1E8FD013B63F523"><enum>(A)</enum><text>in subsection (a), by striking <quote>(a) <header-in-text level="subsection" style="OLC">In general</header-in-text>.—</quote>; and</text>
 </subparagraph><subparagraph id="id94C85EC9796A4BD38E3B84B4C0141E1C"><enum>(B)</enum><text>by striking subsection (b) (<external-xref legal-doc="usc" parsable-cite="usc/21/1532">21 U.S.C. 1532</external-xref> note); and</text> </subparagraph></paragraph><paragraph id="id77d64b953bb441398026f723752137c2"><enum>(2)</enum><text>by repealing sections 1103, 1104, 1109, 1111, and 1114 (120 Stat. 3540, 3543, and 3544).</text>
				</paragraph></section></title></legis-body>
</bill>


